Daiwa Securities Adjusts PT on Gilead Sciences to $150 From $161, Maintains Outperform Rating

MT NewswiresMay 19 05:52 ET

Gilead Sciences Insider Sold Shares Worth $3,676,199, According to a Recent SEC Filing

MT NewswiresMay 18 17:53 ET

Argus Research Sticks to Its Buy Rating for Gilead Sciences (GILD)

TipRanksMay 18 13:15 ET · Ratings

The WHO has again raised the alarm over the Ebola outbreak. What do we currently know?

① The WHO announced that the Ebola outbreaks in the Democratic Republic of the Congo (DRC) and Uganda constitute a "Public Health Emergency of International Concern"; ② The strain currently spreading is the less common "Bundibugyo" type, for which existing vaccines and antibody therapies offer limited coverage; ③ The WHO warned that the cases identified so far may only represent the tip of the iceberg, while emphasizing that the outbreak has not yet reached the level of a global pandemic.

cls.cnMay 18 08:47 ET

Strategies for Staying a Step Ahead of Inflation -- Barron's

Barron'sMay 15 21:31 ET

Express News | Mubadala Investment Co Pjsc - Change in Holdings Are as of March 31, 2026, and Compared With the Previous Quarter Ended as of Dec 31, 2025

ReutersMay 15 10:58 ET